Alnylam Pharmaceuticals (NASDAQ:ALNY) reported 9/30/2018 earnings this Morning, coming in at ($2.43) per share, missing Wall Street’s estimates of ($2.03) per Share. Revenue for the quarter came in at $2.07 million missing the streets estimates of $22.66 million
Recent Trading for Alnylam Pharmaceuticals (NASDAQ:ALNY) Shares of Alnylam Pharmaceuticals closed the previous trading session at with 79.55 shares trading hands.